On The Pen With Dave Knapp

• GLP-1 Access Progress + The Race for Less Frequent Dosing: OTP TWD 6.10.25

  https://www.linktr.ee/manonthemounjaro Ozempic rare eye disease update The the race for once monthly dosing Big insurance wins incoming?!

  --------  

  22:33
• Lilly Makes Bold Move on GLP Dosing / 8x More Ozempic? / Wegovy Use in Teens

  VIEW ALL OF OUR LINKS: https://linktr.ee/manonthemounjaro JOIN OUR SUBSTACK: HTTP://WWW.ONTHEPEN.SUBSTACK.COM

  --------  

  21:18
• Trump Admin Setting Price Targets for Zepbound and Ozempic, Will Pharma Go Along?

  Join the Substack here: onthepen.substack.com Get all my links here: https://linktr.ee/manonthemounjaro

  --------  

  29:47
• Zepbound vs. Wegovy, CVS vs. Patients, and the Executive Order That Changes Everything

  Joe's Petition + All My Links: https://linktr.ee/manonthemounjaro

  --------  

  41:02
• Compound Tirzepatide Lawsuit + PBM Reform Update // OTP TWD 5.6.25

  Dave discussed the latest update in the OFA vs FDA compound tirzepatide battle, as well as this weeks news in obesity medicine. Find our substack and all promotional links here: https://linktr.ee/manonthemounjaro

  --------  

  26:31

More Health & Wellness podcasts

Trending Health & Wellness podcasts

About On The Pen With Dave Knapp